As China embraces AI, only 24% of US pharmaceutical execs bet on it for innovation
SCMP Tech (AI)en
SCMP Tech (AI)
AI Global WireSurvey finds drug companies planned to scale AI or had already done so, but few anticipated a ‘wholesale revolution’ from the tech.
This is a short summary published by AI Global Wire. The full article is owned and hosted by SCMP Tech (AI) — open it there to read it in full.
Read the full story at SCMP Tech (AI)Related AI news
- Udviklingen af kunstig intelligens bliver sammenlignet med atomkapløbet. Måske kan en erfaring fra dengang være en del af løsningenDR Viden · September 10, 2026
- OpenAI says it will pause new $200/month ChatGPT Pro subscriptions amid "unprecedented" Astra demand; existing accounts, other plans, and API are unaffected (Tibo/@thsottiaux)Techmeme · September 10, 2026
- Universal Music Group partners with ElevenLabs to launch a new AI-powered platform that will let users create song remixes, mashups, and more from its catalog (Emma Roth/The Verge)Techmeme · September 10, 2026
- Panic builds over bankrupt Spirit’s looming data sale to GoogleArs Technica AI · September 10, 2026
- OpenAI unveils ChatGPT for Financial Services, a version of ChatGPT Work made with "design partners" Morgan Stanley and Evercore to research like an analyst (CNBC)Techmeme · September 10, 2026
- Anthropic reveals rogue AI agents hate CAPTCHAs, just like youTechCrunch AI · September 10, 2026